← back to search

Geert Mayer

McGill University Health Centre · CA
Area of research
Cognitive Neuroscience · Experimental and Cognitive Psychology
Research interest
Research interests include Medicine, Narcolepsy, Epworth Sleepiness Scale, Excessive daytime sleepiness, REM sleep behavior disorder, and Psychiatry.
h-index
citations
3,525
works
22
NIH funding
primary concept
email

Recent publications

Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy
Nature Communications 2023cited by 58position: middledoi
Solriamfetol real world experience study (SURWEY): Initiation, titration, safety, effectiveness, and experience during follow-up for patients with narcolepsy from Germany
Sleep Medicine 2023cited by 10position: middledoi
Durchführung und Interpretation des multiplen Schlaflatenztests (MSLT) bei Erwachsenen
Somnologie - Schlafforschung und Schlafmedizin 2023cited by 0position: middledoi
Aktuelle Entwicklungen in der Schlafforschung und Schlafmedizin – eine Einschätzung der AG „Narkolepsie, Hypersomnie und Hypersomnolenz“
Somnologie - Schlafforschung und Schlafmedizin 2022cited by 0position: lastdoi
Video-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study Group
SLEEP 2021cited by 158position: middledoi
Kleine-Levin syndrome is associated with birth difficulties and genetic variants in the <i>TRANK1</i> gene loci
Proceedings of the National Academy of Sciences 2021cited by 46position: middledoi
Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea
Journal of Clinical Sleep Medicine 2021cited by 21position: middledoi
Levels of GHB in hair after regular application
Forensic Science International 2021cited by 10position: middledoi
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
Brain 2019cited by 1,078position: middledoi
Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
Nature Reviews Neurology 2019cited by 618position: middledoi
Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea
SLEEP 2019cited by 249position: middledoi
Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder
npj Parkinson s Disease 2019cited by 32position: middledoi
Longitudinal assessment of excessive daytime sleepiness in early Parkinson’s disease
Journal of Neurology Neurosurgery & Psychiatry 2017cited by 112position: middledoi
German S3 Guideline Nonrestorative Sleep/Sleep Disorders, chapter “Sleep-Related Breathing Disorders in Adults,” short version
Somnologie - Schlafforschung und Schlafmedizin 2017cited by 99position: firstdoi
Retrospective multicenter matched case–control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in Germany
Sleep Medicine 2017cited by 15position: middledoi
The European Narcolepsy Network (<scp>EU</scp>‐<scp>NN</scp>) database
Journal of Sleep Research 2016cited by 61position: middledoi
Comparing Treatment Effect Measurements in Narcolepsy: The Sustained Attention to Response Task, Epworth Sleepiness Scale and Maintenance of Wakefulness Test
SLEEP 2015cited by 61position: middledoi
Incidence of Narcolepsy in Germany
SLEEP 2015cited by 45position: middledoi
Internationale Klassifikation der Schlafstörungen: Übersicht über die Änderungen in der ICSD-3
Somnologie - Schlafforschung und Schlafmedizin 2015cited by 24position: firstdoi
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
The Lancet Neurology 2013cited by 350position: middledoi
ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy
PLoS Genetics 2013cited by 245position: middledoi
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group
Sleep Medicine 2013cited by 233position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Peter Geisler · University of Regensburg4 papers (2015–2023)Ulf Kallweit · Witten/Herdecke University4 papers (2019–2023) · 3 papers (2013–2019) · 3 papers (2021–2023)Nancy Foldvary‐Schaefer · Case Western Reserve University3 papers (2017–2021)Claudio L. Bassetti · Université Grenoble Alpes3 papers (2013–2019)Yves Dauvilliers · Centre Hospitalier Universitaire de Tours3 papers (2013–2019) · 2 papers (2013–2015)Doris Oberle · University Hospital Heidelberg2 papers (2015–2017)Richard J. Schwab · California University of Pennsylvania2 papers (2019–2021)Michelle Baladi · Jazz Pharmaceuticals (United States)2 papers (2019–2021)Birgit Högl · McGill University Health Centre2 papers (2017–2021)Atul Malhotra · Monash Health2 papers (2019–2021)Colin M. Shapiro · University of Toronto2 papers (2019–2021)Jean‐Louis Pépin · Agir Pour les Maladies Chroniques2 papers (2019–2021)Isabelle Arnulf · Centre National de la Recherche Scientifique2 papers (2013–2015)Christian Veauthier · Wittenberg University2 papers (2022–2023)Aleksandar Videnović · Harvard University2 papers (2017–2021) · 2 papers (2015–2017)Lawrence Lee · National University of Singapore2 papers (2019–2021)